Sayre Therapeutics Pvt Ltd
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Sayre Therapeutics Pvt Ltd - overview
Established
2015
Location
Bangalore, Karnataka, India
Primary Industry
Pharmaceuticals
About
Founded in 2015 and based in Bengaluru, Karnataka, Sayre Therapeutics Pvt Ltd operates as a pharmaceutical company that develops novel drugs for the treatment of oncology and auto-immune disorders.
Current Investors
Accel, Aarin Capital, InnoVen Capital
Primary Industry
Pharmaceuticals
Sub Industries
Molecular Science, Genetics & Gene Therapy, Pharmaceutical Research & Development
Website
www.sayretherapeutics.com
Company Stage
Series A
Total Amount Raised
Subscriber access only
Sayre Therapeutics Pvt Ltd - timeline of key events
Sayre Therapeutics Pvt Ltd - financials
| Fiscal Year Ended | Mar 31, 2016 | Mar 31, 2017 | Mar 31, 2018 | Mar 31, 2019 | Mar 31, 2020 | Mar 31, 2021 | Mar 31, 2022 | Mar 31, 2023 | Mar 31, 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 11,511,732 | 50,167,153 | 81,496,165 | 96,877,126 | 125,419,872 | 92,038,851 | - | - | - |
| % Revenue Growth (YoY) | - | 335.8% | 62.4% | 18.9% | 29.5% | (26.6%) | - | - | - |
| EBITDA (USD) | (40,992,854) | (60,768,302) | (54,731,970) | (70,726,443) | (41,488,952) | (24,718,144) | - | - | - |
| Operating Income (USD) | (41,274,125) | (61,352,534) | (55,179,092) | (70,966,657) | (41,589,084) | (24,755,494) | - | - | - |
| Operating Margin | (358.5%) | (122.3%) | (67.7%) | (73.3%) | (33.2%) | (26.9%) | - | - | - |
| % EBITDA Margin | (356.1%) | (121.1%) | (67.2%) | (73.0%) | (33.1%) | (26.9%) | - | - | - |
| NET Income (USD) | (40,955,238) | (60,871,400) | (64,403,026) | (76,586,058) | (45,637,929) | (31,823,670) | - | - | - |
| % Net Margin | (355.8%) | (121.3%) | (79.0%) | (79.1%) | (36.4%) | (34.6%) | - | - | - |
Sayre Therapeutics Pvt Ltd - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.